Facebook Twitter RSS Feed

You are here

Coronary Intervention & Surgery

 - blood clot, platelets, vein

Compared with heparin, bivalirudin increases the risk of major adverse cardiac events but reduces the risk of bleeding to varying degrees in patients undergoing PCI, a meta-analysis published in the Aug. 16 issue of The Lancet concluded.

 - aspirin

Aspirin dosing patterns after MI seem to favor high doses, regardless of bleeding risks, according to a study published online Aug. 12 in Circulation: Cardiovascular Quality & Outcomes.

 - Neon Heart

While coronary artery disease (CAD) patients with both ischemia and angina proved to have higher risks for mortality, 58.2 percent of patients without symptoms died of cardiovascular- or MI-related causes, according to a study published online Aug. 11 in JAMA: Internal Medicine.

 - Washington

The Transcatheter Cardiovascular Therapeutics (TCT) conference announced its lineup for late-breaking clinical trials and first report investigations that will be a presented Sept. 13-15 at the scientific sessions in Washington, D.C.

 - Glass Half Full

Lowering the amount of contrast used and encouraging more oral hydration before and after a PCI procedure reduced contrast-induced acute kidney injury by 21 percent, according to a study published online July 29 in Circulation: Cardiovascular Quality and Outcomes

 

More Stories

Some prasugrel prescribing runs counter to labeling

Prescribing patterns for the anticoagulant prasugrel suggest that there is ample room for improvement.

PCI volume-outcome link holds but threshold is unclear

Volume appears to be key in quality outcomes for PCI, however, the threshold number a provider must perform per year to stay in top form remains elusive, a study published June 17 in Circulation: Cardiovascular Quality and Outcomes stated.

Patient radiation dose drops 61% with imaging changes

Interventional cardiologists reduced the radiation dose in patients with congenital heart disease by 61 percent using a combination of practice and technical changes, according to a study published online June 20 in Catheterization and Cardiovascular Interventions. Most pediatric and adult patients benefited from the revised protocol.

Left radial PCI reduces operators’ radiation exposure by half

Radiation exposure to the operator was nearly half when performing PCI by a left radial approach rather than right, according to a study published online June 18 in the Journal of the American College of Cardiology: Cardiovascular Interventions

Angiography as good as FFR & IVUS for post-PCI long-term survival

While fractional flow reserve (FFR) and intravascular ultrasound (IVUS) may reduce the need for repeat revascularization, they apparently don’t make a dent in long-term mortality compared with angiography-guided PCI. But FFR may help reduce stent use, according to results published online June 23 in JAMA Internal Medicine.

Preoperative beta-blocker use may not help with CABG

The latest study to examine the preoperative use of beta-blockers in CABG found no mortality benefit combined with an uptick in postoperative atrial fibrillation. Still, it probably is not time to take an eraser to related quality metrics or guidelines. 

A break for CABG? Readmissions measure uses clinical data

With penalties for higher-than-expected 30-day readmissions for CABG on the horizon, concerns about how hospitals will be measured have been growing. A method that linked clinical data to administrative data may provide an answer.

Increasing radial PCI use even slightly may lower bleeding rates

Hospitals that readily embraced transradial PCI over a three-year period were more likely to see reduced bleeding rates, an analysis of CathPCI data showed. But even facilities that had modest increases in radial PCI use achieved lower access site and overall bleeding rates.

Off-pump CABG shows short- but not long-term kidney benefits

Patients who underwent off-pump CABG surgery were less likely than on-pump patients to experience postoperative acute kidney injury, based on an analysis of CORONARY data published in the June 4 issue of JAMA. But kidney function remained similar between the groups at one year.

Hospital pays $41M to settle overstenting case

A hospital in Kentucky agreed to pay almost $41 million to put a case alleging unnecessary cardiac stenting and diagnostic catheterizations behind it.

1 in 3 patients don’t fill clopidogrel script soon after PCI

One third of patients who were discharged after a PCI failed to fill their clopidogrel prescriptions within three days, according to a study published online May 28 in Journal of the American Heart Association, at the risk of serious consequences. Findings showed that the time following hospital release to the filling of the prescription dramatically influences outcomes.

Spectranetics acquires balloon catheter company

Spectranetics Corp. and AngioScore penned a $230 million deal to serve the peripheral and coronary markets by making AngioScore a wholly owned subsidiary of Spectranetics.  

FDA clears vorapaxar to reduce MI, stroke risks

The FDA approved the antiplatelet drug vorapaxar to reduce the risk of an MI, stroke or cardiovascular death in patients with a prior MI or peripheral artery disease.

FDA rejects bid to market cangrelor

The FDA rebuffed The Medicines Company in its quest for approval of the antiplatelet agent cangrelor.

An exclusive club? Non-system delays may bolster reported D2B times

An assessment of hospitals that perform primary PCI found a four-fold difference between facilities that frequently and rarely exclude patients based on non-system delays in reports on door-to-balloon (D2B) times. The variation affected compliance to the D2B metric.

Protocol slashes radiation dose but not cath lab volume

Operators reduced radiation dose 48 percent with no loss in volumes or interventions using a novel algorithm in the catheterization laboratory, researchers reported online April 16 in the Journal of the American College of Cardiology: Cardiovascular Interventions.

Radial PCI learning curve ranges from 30 to 50 cases in U.S.

The learning curve for transradial PCI in the U.S. is “relatively shallow” and similar to that for operators outside the U.S., according to an analysis of CathPCI Registry data that was published online April 22 in Circulation.

Drug-eluting stents match bare metal stents in NEXT

Drug-eluting stents may be as safe a choice as bare metal stents when followed by a blood thinning regimen tailored to individual patients, based on the results of a research letter published March 31 in the JAMA.

Operators slice radiation dose by 48% after workshop

Interventional cardiologists who participated in a 90-minute course that emphasized radiation safety principals reduced patient radiation dose by 48 percent in diagnostic catheterizations.

Societies offer go-to resource for PCI centers without surgical backup

PCI centers that don’t provide on-site surgical backup caught a break on March 17 with the publication of a paper that consolidates recommendations into a single document. “We tried to take everything that has been out there and put it all in one resource so people don’t have to hunt around,” lead author Gregory J. Dehmer, MD, told Cardiovascular Business.